Search Results - A. L. Bakulev

Methotrexate: Revisited efficiency and safety of drug administration in psoriasis patients by A. L. Bakulev

Connect to this object online.

Strategy "treat to target" for patients with psoriasis. Relevant issues to biological therapy persistence by A. L. Bakulev

Connect to this object online.

Evolution of the understanding of psoriasis and therapeutic approaches used to manage such patients. BCD-085 is the first Russian genetically-engineered biological preparation for... by A. L. Bakulev

Connect to this object online.

Selective intracellular inhibition of signalling pathways - new direction in systematic treatment of psoriasis patients by A. L. Bakulev

Connect to this object online.

Results of the long-term observational noninterventional prospective study BODYGUARD in psoriasis patients by A. L. Bakulev, D. D. Petrunin

Connect to this object online.

Microbial eczema: up-to-date topical treatment with silver sulfathiazole by A. L. Bakulev, S. S. Kravchenya, A. N. Platonova

Connect to this object online.

Dermatoscopy in the diagnosis of pigmented nevi by A. L. Bakulev, O. M. Konopatskova, Yu. V. Stanchina

Connect to this object online.

Using clobetasol propionate in the form of a shampoo for the treatment of patients suffering from psoriasis localized in the scalp area by A. L. Bakulev, S. S. Kravchenya, I. A. Igonina, S. R. Utz

Connect to this object online.

Long-term therapy of severe acne: selection of doses and administration schemes for systemic isotretinoin by A. L. Bakulev, S. S. Kravchenya, A. N. Platonova, I. A. Igonina

Connect to this object online.

A case of localized bullous scleroderma by A. L. Bakulev, E. M. Galkina, A. V. Karakaeva, M. V. Litvinenko

Connect to this object online.

Endothelial dysfunction and its treatment in psoriasis patients by Yu. M. Shtoda, N. A. Slesarenko, A. L. Bakulev, S. R. Utz, A. N. Platonova

Connect to this object online.

Psoriasis: clinical and epidemiological features and therapy issues by A. L. Bakulev, T. V. Fitileva, E. А. Novodezerkina, I. Gilloteau, Н. Tian, T. Howe, G. Pietri

Connect to this object online.

A case of a combination of Crocker - Adamson follicular spinulosa, lichen acuminatus and Little - Lassueur syndrome by N. A. Slesarenko, S. R. Utz, A. L. Bakulev, V. A. Davtyan, A. YU. Yepifanova, YE. M. Reshetnikova, YU. M. Shtoda

Connect to this object online.

Revisiting the question of psoriasis classification by A. E. Karamova, O. Y. Olisova, A. L. Bakulev, M. M. Kokhan, V. R. Khairutdinov, E. V. Sokolovskiy, M. M. Khobeych

Connect to this object online.

Efficacy and Safety of BCD-085, a Novel Interleukin-17 Inhibitor. Results of Phase II Clinical Trial in Patients with Moderate-to-Severe Plaque Psoriasis by A. V. Samtsov, V. R. Khairutdinov, A. L. Bakulev, A. A. Kubanov, A. E. Karamova, A. V. Artem'eva, T. V. Korotaeva

Connect to this object online.

Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis by A. A. Kubanov, A. L. Bakulev, M. I. Gluzmin, M. M. Kokhan, L. S. Kruglova, N. S. Rudneva, O. Yu. Olisova, E. V. Sokolovsky, M. M. Khobeish

Connect to this object online.

Long-term efficacy and safety of netakimab in patients with moderate-to-severe psoriasis. Results of phase II open-label extension clinical study BCD-085-2-ext by A. L. Bakulev, A. V. Samtsov, A. A. Kubanov, V. R. Khairutdinov, M. M. Kokhan, A. V. Artemyeva, S. I. Derbin, E. V. Chernyaeva, R. A. Ivanov

Connect to this object online.

Netakimab - new IL-17а inhibitor: 12-week results of phase III clinical study BCD-085-7/PLANETA in patients with moderate-tosevere plaque psoriasis by A. A. Kubanov, A. L. Bakulev, A. V. Samtsov, V. R. Khairutdinov, E. V. Sokolovskiy, M. M. Kokhan, A. V. Artemyeva, E V. Chernyaeva, R. A. Ivanov

Connect to this object online.